Heparin Sodium
NDC Package 0641-2450-55
Package Information
Heparin Sodium is injection is indicated for:Prophylaxis and treatment of venous thrombosis and pulmonary embolism; Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease;Atrial fibrillation with embolization;Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation);Prevention of clotting in arterial and cardiac surgery;Prophylaxis and treatment of peripheral arterial embolism.Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. Marketed by Hikma Pharmaceuticals Usa Inc., this product is identified by NDC 0641-2450 and is authorized under FDA application NDA017037.
Identification & Billing
- RxCUI: 1361226 - heparin sodium, porcine 1000 UNT/ML Injectable Solution
- RxCUI: 1361615 - heparin sodium, porcine 5000 UNT/ML Injectable Solution
- RxCUI: 1362831 - heparin sodium, porcine 10,000 UNT/ML Injectable Solution
- RxCUI: 1362831 - heparin sodium, porcine 10000 UNT/ML Injectable Solution
- RxCUI: 1659263 - heparin sodium, porcine 5000 UNT in 1 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0641 - Hikma Pharmaceuticals Usa Inc.
- 0641-2450 - Heparin Sodium
- 0641-2450-55 - 25 VIAL, MULTI-DOSE in 1 PACKAGE / 30 mL in 1 VIAL, MULTI-DOSE (0641-2450-30)
- 0641-2450 - Heparin Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0641-2450-55 identifies a specific commercial package of 25 vial, multi-dose in 1 package / 30 ml in 1 vial, multi-dose (0641-2450-30) of Heparin Sodium, labeled by Hikma Pharmaceuticals Usa Inc.. This product is billed per "ML" milliliter and contains an estimated amount of 750 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hikma Pharmaceuticals Usa Inc. on March 22, 1972. The current certification is valid through January 31, 2021.
How is this Hikma Pharmaceuticals Usa Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00641245055. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 750 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.